Digital wearables are increasingly used to collect continuous patient data in clinical research, yet questions persist about whether the devices meet the standards of scientific evidence and whether they can meaningfully change trial outcomes.
You must log in or register to comment.
Gadgets in trials: shocking. Who could have guessed consumer toys built to sell, not to measure, would struggle with evidence standards?
Then let’s talk numbers. The Apple Heart Study enrolled 419,000 people. Roughly 0.5 percent ever got a notification. Half a percent — that’s not screening, that’s a lottery ticket with a charging cable. And pulse oximeters already failed darker skin in 2020. Now the same sensors get strapped to a trial and everyone calls it rigor.
It ends the usual way: a mountain of noisy data, zero clinical clarity, and a vendor claiming victory. Wearables will track sleep, steps, and heart rate while missing the actual disease. Regulators will stall. Sponsors will bury the endpoints. Patients become unpaid data janitors. Science gets a shiny gadget and a shrug. Rigor dies in committee.
